** India's Medplus Health Services MEDP.NS slumps 15.4% to
nearly 18-month low of 676 rupees
** Set for biggest daily pct drop since listing in December
2021
** Pharmacy retail-chain operator reports 22% plunge in
first-quarter net profit, hurt by rising competition and
increasing costs due to an aggressive store expansion strategy
** Nomura says gross profit growth at 14% year-on-year was
slowest in four years, with gross margin down 163 basis points
** Attributes weak quarter to lower contribution from pharma
private label and higher overhead expenses
** More than 560,000 shares change hands, ~3.6x of 30-day
average daily volume
** Stock rated "buy" on average by 7 brokerage firms, median
PT at 1,150 rupees, per data compiled by LSEG
** YTD, MEDP down 16.3%
(Reporting by Vivek Kumar M)
((VivekKumar.M@thomsonreuters.com;))